Program News
News and stories about members of the UNC Lineberger Tumor Virology Research Program
-
UNC study reveals promising new therapy for non-Hodgkin lymphoma
The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma.
-
Two UNC School of Medicine researchers receive $1 million grants to advance innovative cancer research
Justin Milner, PhD, and Carla Chibwesha, MD, MSc, have each received a $1 million grant from AACR. The investment will support their work aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.
-
UNC Lineberger and UNC faculty and trainees scheduled to present findings at American Association of Cancer Research Annual Meeting
UNC Lineberger researchers will present findings, chair sessions, lead session discussions and share their perspectives in topical forums and education sessions during the AACR Annual Meeting.
-
UNC research shows natural compound could benefit lymphoma patients
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
Five UNC Lineberger members named distinguished professors
Five cancer center members were named distinguished professors, an honor recognizing those who exemplify the highest standards of UNC through their scholarly achievement, teaching excellence and service.
-
UNC Lineberger members recognized for highly cited research
Nine UNC Lineberger members wrote some of the most influential scientific papers in the past decade, according to an independent analysis of research publications.
-
Scientists implicate a novel cellular protein in hepatitis A infection
A collaboration between Stanley M. Lemon, MD, and fellow infectious diseases colleagues at the UNC School of Medicine has unveiled a crucial role for a protein called PDAP1 in hepatitis A virus infection of the liver.